These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12913779)

  • 1. Recombinant activated protein C in pediatric sepsis.
    Dalton HJ
    Pediatr Infect Dis J; 2003 Aug; 22(8):743-5. PubMed ID: 12913779
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activated protein C, coagulation, inflammation and treatment of severe sepsis].
    Ott A
    Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2196-7. PubMed ID: 11727624
    [No Abstract]   [Full Text] [Related]  

  • 3. [Activated protein C, coagulation, inflammation and treatment of severe sepsis].
    van Zanten AR; Bakker J; van den Berg PC; Girbes AR; van Leeuwen SJ
    Ned Tijdschr Geneeskd; 2001 Jun; 145(24):1179. PubMed ID: 11433670
    [No Abstract]   [Full Text] [Related]  

  • 4. [Activated protein C, coagulation, inflammation and treatment of severe sepsis].
    Bartelink AK; van Deuren M
    Ned Tijdschr Geneeskd; 2001 Jun; 145(24):1178-9. PubMed ID: 11433669
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjunctive corticosteroid therapy in pediatric severe sepsis: many unsolved questions.
    Leclerc F; Botte A; Chêne G; Leteurtre S
    Pediatr Crit Care Med; 2011 Jan; 12(1):101-2. PubMed ID: 21209569
    [No Abstract]   [Full Text] [Related]  

  • 6. [Activated protein C, coagulation, inflammation, and treatment of severe sepsis].
    van Deventer SJ; Pajkrt D
    Ned Tijdschr Geneeskd; 2001 Mar; 145(13):613-6. PubMed ID: 11305209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation committees: the time is right but is the timing right?
    Teplick R
    Crit Care Med; 2003 Sep; 31(9):2403-5. PubMed ID: 14501976
    [No Abstract]   [Full Text] [Related]  

  • 8. [Exogenous activated protein C in severe sepsis].
    Mamontova OA; Protsenko DN; Eliutin DV; Kirienko PN; Gel'fand BR
    Anesteziol Reanimatol; 2005; (3):42-5. PubMed ID: 16076046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protein C concentrate in the treatment of severe sepsis in the pediatric setting].
    Ramos Guerrero R; López Castilla JD; Atienza Fernández M; Bautista Paloma J; Ramos Guerrero AJ; Muñoz Sáez M; Carranza Conde M; Soult Rubio JA
    Farm Hosp; 2003; 27(6):391-5. PubMed ID: 14974885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated protein C for the treatment of severe sepsis.
    Houston G; Cuthbertson BH
    Clin Microbiol Infect; 2009 Apr; 15(4):319-24. PubMed ID: 19416303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive corticosteroid therapy in pediatric severe sepsis: observations from the RESOLVE study.
    Zimmerman JJ; Williams MD
    Pediatr Crit Care Med; 2011 Jan; 12(1):2-8. PubMed ID: 20228689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein C may be sepsis solution.
    Garber K
    Nat Biotechnol; 2000 Sep; 18(9):917-8. PubMed ID: 10973198
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adjuvant therapies for sepsis and shock: which are more effective?].
    Groeneveld AB; Beishuizen A; Appelmelk BJ; Girbes AR
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1718-22. PubMed ID: 11572169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Only activated protein C treatment and not protein C has demonstrated an improvement in survival in severe sepsis.
    Yan SB; Dhainaut JF; Schwarz HP; Ehrlich HJ
    Crit Care Med; 2004 Feb; 32(2):618; author reply 618-9. PubMed ID: 14758203
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sepsis therapy -- how effective are the therapy strategies?].
    Brunkhorst F; Reinhart K
    Chirurg; 2008 Sep; 79(9):877-8. PubMed ID: 18942197
    [No Abstract]   [Full Text] [Related]  

  • 16. Benefit of recombinant human activated protein C beyond 28-day mortality: there is more to life than death.
    Levi M
    Crit Care Med; 2003 Mar; 31(3):984-5. PubMed ID: 12627023
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant activated protein C: the key is clinical assessment of risk of death, not subset analysis.
    Dellinger RP
    Crit Care; 2006 Feb; 10(1):114. PubMed ID: 16542472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe sepsis, coagulation, and fibrinolysis: dead end or one way?
    Fourrier F
    Crit Care Med; 2012 Sep; 40(9):2704-8. PubMed ID: 22732284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we RESOLVE the treatment of sepsis?
    Opal SM
    Lancet; 2007 Mar; 369(9564):803-804. PubMed ID: 17350431
    [No Abstract]   [Full Text] [Related]  

  • 20. Substantiating the concerns about recombinant human activated protein C use in sepsis.
    Deans KJ; Minneci PC; Banks SM; Natanson C; Eichacker PQ
    Crit Care Med; 2004 Dec; 32(12):2542-3. PubMed ID: 15599164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.